Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex

Abstract excerpt

Tuberous sclerosis complex (TSC) is a genetic autosomal dominant disorder characterized by benign tumor-like lesions, called hamartomas, in multiple organ systems, including the brain, skin, heart, kidneys, and lung. These hamartomas cause a diverse set of clinical problems based on their location and often result in epilepsy, learning difficulties, and behavioral problems. TSC is caused by mutations within the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Tuberous Sclerosis Complex Research
• Share to Vascular Tumors and Angiosarcomas